Allworth Financial’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7K Buy
6,480
+4,304
+198% +$10.5K ﹤0.01% 3383
2026
Q1
$5.16K Buy
2,176
+2,017
+1,269% +$6.99K ﹤0.01% 3943
2025
Q4
$824 Buy
159
+158
+15,800% +$766 ﹤0.01% 4413
2025
Q3
$5 Buy
+1
New +$5 ﹤0.01% 4892
2025
Q2
Sell
-228
Closed -$1.03K 4653
2025
Q1
$1.03K Buy
+228
New +$921 ﹤0.01% 3454
2023
Q1
Sell
-168
Closed -$452 3266
2022
Q4
$452 Buy
+168
New +$490 ﹤0.01% 2660

Other funds holding ORGO

Allworth Financial's ORGO Position: Q2 2026 in Review

Allworth Financial increased its Organogenesis Holdings (ORGO) stake by 198% in Q2 2026, buying an estimated $10.5K and bringing the position to 6,480 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3383.

Allworth Financial first reported a position in ORGO in Q4 2022 and has held it in 6 quarters since. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Allworth Financial held 6,480 shares of Organogenesis Holdings worth $15.7K as of Q2 2026.
  • Allworth Financial bought 4,304 Organogenesis Holdings shares in Q2 2026, an estimated $10.5K.
  • Organogenesis Holdings made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3383 holding.
  • Allworth Financial first reported a position in Organogenesis Holdings in Q4 2022 and has held it in 6 quarters since.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.